Last 12 months
Inside the activity.
0 purchase rows · 95 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 8 |
| Jan 2026 | 0 | 11 |
| Feb 2026 | 0 | 9 |
| Mar 2026 | 0 | 9 |
| Apr 2026 | 0 | 6 |
| May 2026 | 0 | 7 |
| Jun 2026 | 0 | 8 |
| Jul 2026 | 0 | 7 |
| Aug 2026 | 0 | 6 |
| Sep 2026 | 0 | 21 |
| Oct 2026 | 0 | 3 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 01, 2026 Filed Apr 2, 2026 16:06 UTC |
Bachrodt AmySVP, Finance
|
SaleCommon Stock | 2,200 | $29.32 | $64,509.94 |
DisclosureSEC source: 0002050422-26-000012 · form4-04022026_080443.xml · nonDerivative · entry 2 Bachrodt Amy · CIK 0002050422 · SVP, Finance 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 13,265 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025. F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.85 to $29.82 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and in footnote 3 of this Form 4. Read SEC document |
| April 01, 2026 Filed Apr 2, 2026 16:06 UTC |
Bachrodt AmySVP, Finance
|
Exercise / conversionCommon Stock | 2,500 | $10.42 | $26,050.00 |
DisclosureSEC source: 0002050422-26-000012 · form4-04022026_080443.xml · nonDerivative · entry 1 Bachrodt Amy · CIK 0002050422 · SVP, Finance 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 15,465 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025. Read SEC document |
| April 01, 2026 Filed Apr 2, 2026 20:08 UTC |
Bernstein HaroldPresident, R&D & CMO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $10.42 | $0.00 |
DisclosureSEC source: 0002050172-26-000019 · form4-04022026_080416.xml · derivative · entry 5 Bernstein Harold · CIK 0002050172 · President, R&D & CMO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 237,407 Underlying: Common Stock · 15,000 shares Expires 2032-10-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025. F5 · derivative.exercise_date: The option vested as to 1/4th of the total award on October 3, 2023, and thereafter vested or vests as to 1/48th of the total award on the monthly anniversary thereof, subject to the reporting person's continued service to the Issuer on each vesting date. Read SEC document |
| April 01, 2026 Filed Apr 2, 2026 20:08 UTC |
Bernstein HaroldPresident, R&D & CMO
|
SaleCommon Stock | 300 | $31.07 | $9,320.01 |
DisclosureSEC source: 0002050172-26-000019 · form4-04022026_080416.xml · nonDerivative · entry 4 Bernstein Harold · CIK 0002050172 · President, R&D & CMO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025. F4 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.80 to $31.22 per share, inclusive. Read SEC document |
| April 01, 2026 Filed Apr 2, 2026 20:08 UTC |
Bernstein HaroldPresident, R&D & CMO
|
SaleCommon Stock | 3,348 | $30.06 | $100,635.86 |
DisclosureSEC source: 0002050172-26-000019 · form4-04022026_080416.xml · nonDerivative · entry 3 Bernstein Harold · CIK 0002050172 · President, R&D & CMO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 300 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025. F3 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.77 to $30.50 per share, inclusive. Read SEC document |
| April 01, 2026 Filed Apr 2, 2026 20:08 UTC |
Bernstein HaroldPresident, R&D & CMO
|
SaleCommon Stock | 11,352 | $29.24 | $331,948.37 |
DisclosureSEC source: 0002050172-26-000019 · form4-04022026_080416.xml · nonDerivative · entry 2 Bernstein Harold · CIK 0002050172 · President, R&D & CMO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 3,648 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025. F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.77 to $29.75 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and in footnotes 3 and 4 of this Form 4. Read SEC document |
| April 01, 2026 Filed Apr 2, 2026 20:08 UTC |
Bernstein HaroldPresident, R&D & CMO
|
Exercise / conversionCommon Stock | 15,000 | $10.42 | $156,300.00 |
DisclosureSEC source: 0002050172-26-000019 · form4-04022026_080416.xml · nonDerivative · entry 1 Bernstein Harold · CIK 0002050172 · President, R&D & CMO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 15,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025. Read SEC document |
| March 30, 2026 Filed Apr 1, 2026 20:12 UTC |
Dandekar AtulCSBO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 7,500 | $0.00 Strike: $10.42 | $0.00 |
DisclosureSEC source: 0002050167-26-000006 · form4-04012026_080428.xml · derivative · entry 4 Dandekar Atul · CIK 0002050167 · CSBO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 51,643 Underlying: Common Stock · 7,500 shares Expires 2031-04-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025. F4 · derivative.exercise_date: The option is fully vested. Pursuant to the terms of the reporting person's award agreement with the Issuer, the award became fully vested on March 17, 2025. Read SEC document |
| March 30, 2026 Filed Apr 1, 2026 20:12 UTC |
Dandekar AtulCSBO
|
SaleCommon Stock | 790 | $30.02 | $23,713.67 |
DisclosureSEC source: 0002050167-26-000006 · form4-04012026_080428.xml · nonDerivative · entry 3 Dandekar Atul · CIK 0002050167 · CSBO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 10,503 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025. F3 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.87 to $30.24 per share, inclusive. Read SEC document |
| March 30, 2026 Filed Apr 1, 2026 20:12 UTC |
Dandekar AtulCSBO
|
SaleCommon Stock | 6,710 | $29.26 | $196,305.08 |
DisclosureSEC source: 0002050167-26-000006 · form4-04012026_080428.xml · nonDerivative · entry 2 Dandekar Atul · CIK 0002050167 · CSBO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 11,293 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025. F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.86 to $29.84 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and in footnote 3 of this Form 4. Read SEC document |
| March 30, 2026 Filed Apr 1, 2026 20:12 UTC |
Dandekar AtulCSBO
|
Exercise / conversionCommon Stock | 7,500 | $10.42 | $78,150.00 |
DisclosureSEC source: 0002050167-26-000006 · form4-04012026_080428.xml · nonDerivative · entry 1 Dandekar Atul · CIK 0002050167 · CSBO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 18,003 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025. Read SEC document |
| March 27, 2026 Filed Mar 31, 2026 20:13 UTC |
Kumar NeilDirector
|
GrantStock Option (Right to Buy) · Derivative | 33,417 | $0.00 Strike: $30.38 | $0.00 |
DisclosureSEC source: 0001742485-26-000003 · form4-03312026_080346.xml · derivative · entry 1 Kumar Neil · CIK 0001742485 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,417 Underlying: Common Stock · 33,417 shares Expires 2036-03-26 F1 · derivative.exercise_date: The option shall vest as to 1/36th of the total award monthly, with the first tranche vesting on April 27, 2026, and each subsequent tranche vesting on the monthly anniversary thereof, subject to the reporting person's continued service to the Issuer on each vesting date. Read SEC document |
| March 20, 2026 Filed Mar 20, 2026 22:50 UTC |
Bernstein HaroldPresident, R&D & CMO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $10.42 | $0.00 |
DisclosureSEC source: 0002050172-26-000017 · form4-03202026_100302.xml · derivative · entry 5 Bernstein Harold · CIK 0002050172 · President, R&D & CMO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 252,407 Underlying: Common Stock · 15,000 shares Expires 2032-10-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025. F5 · derivative.exercise_date: The option vested as to 1/4th of the total award on October 3, 2023, and thereafter vested or vests as to 1/48th of the total award on the monthly anniversary thereof, subject to the reporting person's continued service to the Issuer on each vesting date. Read SEC document |
| March 20, 2026 Filed Mar 20, 2026 22:50 UTC |
Bernstein HaroldPresident, R&D & CMO
|
SaleCommon Stock | 5,044 | $50.02 | $252,293.82 |
DisclosureSEC source: 0002050172-26-000017 · form4-03202026_100302.xml · nonDerivative · entry 4 Bernstein Harold · CIK 0002050172 · President, R&D & CMO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025. F4 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.79 to $50.52 per share, inclusive. Read SEC document |
| March 20, 2026 Filed Mar 20, 2026 22:50 UTC |
Bernstein HaroldPresident, R&D & CMO
|
SaleCommon Stock | 3,795 | $49.32 | $187,168.64 |
DisclosureSEC source: 0002050172-26-000017 · form4-03202026_100302.xml · nonDerivative · entry 3 Bernstein Harold · CIK 0002050172 · President, R&D & CMO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,044 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025. F3 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $48.78 to $49.77 per share, inclusive. Read SEC document |
| March 20, 2026 Filed Mar 20, 2026 22:50 UTC |
Bernstein HaroldPresident, R&D & CMO
|
SaleCommon Stock | 6,161 | $48.20 | $296,976.83 |
DisclosureSEC source: 0002050172-26-000017 · form4-03202026_100302.xml · nonDerivative · entry 2 Bernstein Harold · CIK 0002050172 · President, R&D & CMO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 8,839 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025. F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $47.77 to $48.75 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and in footnotes 3 and 4 of this Form 4. Read SEC document |
| March 20, 2026 Filed Mar 20, 2026 22:50 UTC |
Bernstein HaroldPresident, R&D & CMO
|
Exercise / conversionCommon Stock | 15,000 | $10.42 | $156,300.00 |
DisclosureSEC source: 0002050172-26-000017 · form4-03202026_100302.xml · nonDerivative · entry 1 Bernstein Harold · CIK 0002050172 · President, R&D & CMO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 15,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025. Read SEC document |
| March 10, 2026 Filed Mar 12, 2026 20:51 UTC |
Bernstein HaroldPresident, R&D & CMO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 30,000 | $0.00 Strike: $10.42 | $0.00 |
DisclosureSEC source: 0002050172-26-000015 · form4-03122026_080308.xml · derivative · entry 4 Bernstein Harold · CIK 0002050172 · President, R&D & CMO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 267,407 Underlying: Common Stock · 30,000 shares Expires 2032-10-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025. F4 · derivative.exercise_date: The option vested as to 1/4th of the total award on October 3, 2023, and thereafter vested or vests as to 1/48th of the total award on the monthly anniversary thereof, subject to the reporting person's continued service to the Issuer on each vesting date. Read SEC document |
| March 10, 2026 Filed Mar 12, 2026 20:51 UTC |
Bernstein HaroldPresident, R&D & CMO
|
SaleCommon Stock | 348 | $51.02 | $17,753.22 |
DisclosureSEC source: 0002050172-26-000015 · form4-03122026_080308.xml · nonDerivative · entry 3 Bernstein Harold · CIK 0002050172 · President, R&D & CMO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025. F3 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.00 to $51.09 per share, inclusive. Read SEC document |
| March 10, 2026 Filed Mar 12, 2026 20:51 UTC |
Bernstein HaroldPresident, R&D & CMO
|
SaleCommon Stock | 29,652 | $50.45 | $1,495,807.00 |
DisclosureSEC source: 0002050172-26-000015 · form4-03122026_080308.xml · nonDerivative · entry 2 Bernstein Harold · CIK 0002050172 · President, R&D & CMO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 348 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025. F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.00 to $50.99 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and in footnote 3 of this Form 4. Read SEC document |
| March 10, 2026 Filed Mar 12, 2026 20:51 UTC |
Bernstein HaroldPresident, R&D & CMO
|
Exercise / conversionCommon Stock | 30,000 | $10.42 | $312,600.00 |
DisclosureSEC source: 0002050172-26-000015 · form4-03122026_080308.xml · nonDerivative · entry 1 Bernstein Harold · CIK 0002050172 · President, R&D & CMO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 30,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025. Read SEC document |
| March 02, 2026 Filed Mar 3, 2026 16:20 UTC |
Bachrodt AmySVP, Finance
|
GrantRestricted Stock Units · Derivative | 16,000 | $0.00 | $0.00 |
DisclosureSEC source: 0002050422-26-000010 · form4-03032026_090334.xml · derivative · entry 6 Bachrodt Amy · CIK 0002050422 · SVP, Finance 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 16,000 Underlying: Common Stock · 16,000 shares Expires not disclosed F6 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock upon settlement. F7 · derivative.exercise_date: The restricted stock unit award shall vest in ratable increments of 1/4 of the total award, with the first tranche vesting on March 1, 2027, and vesting thereafter on the one year anniversary of such date, subject to the reporting person's continued service to the Issuer on each vesting date. F8 · derivative.expiration_date: These restricted stock units do not expire; they either vest or are cancelled prior to the vesting date. Read SEC document |
| March 02, 2026 Filed Mar 3, 2026 16:20 UTC |
Bachrodt AmySVP, Finance
|
GrantStock Option (Right to Buy) · Derivative | 32,000 | $0.00 Strike: $45.61 | $0.00 |
DisclosureSEC source: 0002050422-26-000010 · form4-03032026_090334.xml · derivative · entry 5 Bachrodt Amy · CIK 0002050422 · SVP, Finance 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 32,000 Underlying: Common Stock · 32,000 shares Expires 2036-03-01 F5 · derivative.exercise_date: The option award shall vest as to 1/48 of the total award monthly, with the first tranche vesting on April 1, 2026, subject to the reporting person's continued service to the Issuer on each vesting date. Read SEC document |
| March 02, 2026 Filed Mar 3, 2026 16:20 UTC |
Bachrodt AmySVP, Finance
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $10.42 | $0.00 |
DisclosureSEC source: 0002050422-26-000010 · form4-03032026_090334.xml · derivative · entry 4 Bachrodt Amy · CIK 0002050422 · SVP, Finance 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 36,333 Underlying: Common Stock · 5,000 shares Expires 2034-12-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025. F4 · derivative.exercise_date: The option vested or vests as to 1/48th of the total award monthly, with the first tranche vested on January 1, 2025, and each subsequent tranche vesting on the monthly anniversary thereof, subject to the reporting person's continued service to the Issuer on each vesting date. Read SEC document |
| March 02, 2026 Filed Mar 3, 2026 16:20 UTC |
Bachrodt AmySVP, Finance
|
SaleCommon Stock | 3,700 | $45.47 | $168,236.78 |
DisclosureSEC source: 0002050422-26-000010 · form4-03032026_090334.xml · nonDerivative · entry 3 Bachrodt Amy · CIK 0002050422 · SVP, Finance 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 12,965 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025. F3 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.03 to $45.99 per share, inclusive. Read SEC document |
| March 02, 2026 Filed Mar 3, 2026 16:20 UTC |
Bachrodt AmySVP, Finance
|
SaleCommon Stock | 1,300 | $44.44 | $57,773.82 |
DisclosureSEC source: 0002050422-26-000010 · form4-03032026_090334.xml · nonDerivative · entry 2 Bachrodt Amy · CIK 0002050422 · SVP, Finance 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 16,665 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025. F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $44.01 to $44.91 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and in footnote 3 of this Form 4. Read SEC document |
| March 02, 2026 Filed Mar 3, 2026 16:20 UTC |
Bachrodt AmySVP, Finance
|
Exercise / conversionCommon Stock | 5,000 | $10.42 | $52,100.00 |
DisclosureSEC source: 0002050422-26-000010 · form4-03032026_090334.xml · nonDerivative · entry 1 Bachrodt Amy · CIK 0002050422 · SVP, Finance 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 17,965 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025. Read SEC document |
| March 02, 2026 Filed Mar 3, 2026 21:23 UTC |
Bernstein HaroldPresident, R&D & CMO
|
GrantRestricted Stock Units · Derivative | 24,000 | $0.00 | $0.00 |
DisclosureSEC source: 0002050172-26-000013 · form4-03032026_090308.xml · derivative · entry 2 Bernstein Harold · CIK 0002050172 · President, R&D & CMO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,000 Underlying: Common Stock · 24,000 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock upon settlement. F3 · derivative.exercise_date: The restricted stock unit award shall vest in ratable increments of 1/4 of the total award, with the first tranche vesting on March 1, 2027, and vesting thereafter on the one year anniversary of such date, subject to the reporting person's continued service to the Issuer on each vesting date. F4 · derivative.expiration_date: These restricted stock units do not expire; they either vest or are cancelled prior to the vesting date. Read SEC document |
| March 02, 2026 Filed Mar 3, 2026 21:23 UTC |
Bernstein HaroldPresident, R&D & CMO
|
GrantStock Option (Right to Buy) · Derivative | 48,000 | $0.00 Strike: $45.61 | $0.00 |
DisclosureSEC source: 0002050172-26-000013 · form4-03032026_090308.xml · derivative · entry 1 Bernstein Harold · CIK 0002050172 · President, R&D & CMO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,000 Underlying: Common Stock · 48,000 shares Expires 2036-03-01 F1 · derivative.exercise_date: The option award shall vest as to 1/48 of the total award monthly, with the first tranche vesting on April 1, 2026, subject to the reporting person's continued service to the Issuer on each vesting date. Read SEC document |
| March 02, 2026 Filed Mar 3, 2026 21:25 UTC |
Dandekar AtulCSBO
|
GrantRestricted Stock Units · Derivative | 19,000 | $0.00 | $0.00 |
DisclosureSEC source: 0002050167-26-000005 · form4-03032026_090337.xml · derivative · entry 6 Dandekar Atul · CIK 0002050167 · CSBO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 19,000 Underlying: Common Stock · 19,000 shares Expires not disclosed F6 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock upon settlement. F7 · derivative.exercise_date: The restricted stock unit award shall vest in ratable increments of 1/4 of the total award, with the first tranche vesting on March 1, 2027, and vesting thereafter on the one year anniversary of such date, subject to the reporting person's continued service to the Issuer on each vesting date. F8 · derivative.expiration_date: These restricted stock units do not expire; they either vest or are cancelled prior to the vesting date. Read SEC document |
| March 02, 2026 Filed Mar 3, 2026 21:25 UTC |
Dandekar AtulCSBO
|
GrantStock Option (Right to Buy) · Derivative | 38,000 | $0.00 Strike: $45.61 | $0.00 |
DisclosureSEC source: 0002050167-26-000005 · form4-03032026_090337.xml · derivative · entry 5 Dandekar Atul · CIK 0002050167 · CSBO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 38,000 Underlying: Common Stock · 38,000 shares Expires 2036-03-01 F5 · derivative.exercise_date: The option award shall vest as to 1/48 of the total award monthly, with the first tranche vesting on April 1, 2026, subject to the reporting person's continued service to the Issuer on each vesting date. Read SEC document |
| March 02, 2026 Filed Mar 3, 2026 21:17 UTC |
Coloma Jason VDirector · Chief Executive Officer
|
GrantRestricted Stock Units · Derivative | 75,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001676170-26-000002 · form4-03032026_090313.xml · derivative · entry 2 Coloma Jason V · CIK 0001676170 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock upon settlement. F3 · derivative.exercise_date: The restricted stock unit award shall vest in ratable increments of 1/4 of the total award, with the first tranche vesting on March 1, 2027, and vesting thereafter on the one year anniversary of such date, subject to the reporting person's continued service to the Issuer on each vesting date. F4 · derivative.expiration_date: These restricted stock units do not expire; they either vest or are cancelled prior to the vesting date. Read SEC document |
| March 02, 2026 Filed Mar 3, 2026 21:17 UTC |
Coloma Jason VDirector · Chief Executive Officer
|
GrantStock Option (Right to Buy) · Derivative | 150,000 | $0.00 Strike: $45.61 | $0.00 |
DisclosureSEC source: 0001676170-26-000002 · form4-03032026_090313.xml · derivative · entry 1 Coloma Jason V · CIK 0001676170 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 150,000 Underlying: Common Stock · 150,000 shares Expires 2036-03-01 F1 · derivative.exercise_date: The option award shall vest as to 1/48 of the total award monthly, with the first tranche vesting on April 1, 2026, subject to the reporting person's continued service to the Issuer on each vesting date. Read SEC document |
| March 02, 2026 Filed Mar 3, 2026 16:28 UTC |
Courtney PhillipsGC and Corp. Secretary
|
GrantRestricted Stock Units · Derivative | 16,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001782758-26-000002 · form4-03032026_090337.xml · derivative · entry 2 Courtney Phillips · CIK 0001782758 · GC and Corp. Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,000 Underlying: Common Stock · 16,000 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock upon settlement. F3 · derivative.exercise_date: The restricted stock unit award shall vest in ratable increments of 1/4 of the total award, with the first tranche vesting on March 1, 2027, and vesting thereafter on the one year anniversary of such date, subject to the reporting person's continued service to the Issuer on each vesting date. F4 · derivative.expiration_date: These restricted stock units do not expire; they either vest or are cancelled prior to the vesting date. Read SEC document |
| March 02, 2026 Filed Mar 3, 2026 16:28 UTC |
Courtney PhillipsGC and Corp. Secretary
|
GrantStock Option (Right to Buy) · Derivative | 32,000 | $0.00 Strike: $45.61 | $0.00 |
DisclosureSEC source: 0001782758-26-000002 · form4-03032026_090337.xml · derivative · entry 1 Courtney Phillips · CIK 0001782758 · GC and Corp. Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,000 Underlying: Common Stock · 32,000 shares Expires 2036-03-01 F1 · derivative.exercise_date: The option award shall vest as to 1/48 of the total award monthly, with the first tranche vesting on April 1, 2026, subject to the reporting person's continued service to the Issuer on each vesting date. Read SEC document |
| March 02, 2026 Filed Mar 3, 2026 16:30 UTC |
Tahir MisbahChief Financial Officer
|
GrantRestricted Stock Units · Derivative | 20,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001787359-26-000002 · form4-03032026_090333.xml · derivative · entry 2 Tahir Misbah · CIK 0001787359 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock upon settlement. F3 · derivative.exercise_date: The restricted stock unit award shall vest in ratable increments of 1/4 of the total award, with the first tranche vesting on March 1, 2027, and vesting thereafter on the one year anniversary of such date, subject to the reporting person's continued service to the Issuer on each vesting date. F4 · derivative.expiration_date: These restricted stock units do not expire; they either vest or are cancelled prior to the vesting date. Read SEC document |
| March 02, 2026 Filed Mar 3, 2026 16:30 UTC |
Tahir MisbahChief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 40,000 | $0.00 Strike: $45.61 | $0.00 |
DisclosureSEC source: 0001787359-26-000002 · form4-03032026_090333.xml · derivative · entry 1 Tahir Misbah · CIK 0001787359 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2036-03-01 F1 · derivative.exercise_date: The option award shall vest as to 1/48 of the total award monthly, with the first tranche vesting on April 1, 2026, subject to the reporting person's continued service to the Issuer on each vesting date. Read SEC document |
| February 27, 2026 Filed Mar 3, 2026 21:25 UTC |
Dandekar AtulCSBO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 7,500 | $0.00 Strike: $10.42 | $0.00 |
DisclosureSEC source: 0002050167-26-000005 · form4-03032026_090337.xml · derivative · entry 4 Dandekar Atul · CIK 0002050167 · CSBO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 59,143 Underlying: Common Stock · 7,500 shares Expires 2031-04-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025. F4 · derivative.exercise_date: The option is fully vested. Pursuant to the terms of the reporting person's award agreement with the Issuer, the award became fully vested on March 17, 2025. Read SEC document |
| February 27, 2026 Filed Mar 3, 2026 21:25 UTC |
Dandekar AtulCSBO
|
SaleCommon Stock | 3,761 | $45.72 | $171,967.21 |
DisclosureSEC source: 0002050167-26-000005 · form4-03032026_090337.xml · nonDerivative · entry 3 Dandekar Atul · CIK 0002050167 · CSBO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 10,503 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025. F3 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.55 to $46.02 per share, inclusive. Read SEC document |
| February 27, 2026 Filed Mar 3, 2026 21:25 UTC |
Dandekar AtulCSBO
|
SaleCommon Stock | 3,739 | $45.13 | $168,756.03 |
DisclosureSEC source: 0002050167-26-000005 · form4-03032026_090337.xml · nonDerivative · entry 2 Dandekar Atul · CIK 0002050167 · CSBO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 14,264 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025. F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $44.55 to $45.54 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and in footnote 3 of this Form 4. Read SEC document |
| February 27, 2026 Filed Mar 3, 2026 21:25 UTC |
Dandekar AtulCSBO
|
Exercise / conversionCommon Stock | 7,500 | $10.42 | $78,150.00 |
DisclosureSEC source: 0002050167-26-000005 · form4-03032026_090337.xml · nonDerivative · entry 1 Dandekar Atul · CIK 0002050167 · CSBO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 18,003 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025. Read SEC document |
| February 02, 2026 Filed Feb 4, 2026 16:23 UTC |
Bachrodt AmySVP, Finance
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 156 | $0.00 Strike: $10.42 | $0.00 |
DisclosureSEC source: 0002050422-26-000008 · form4-02042026_090208.xml · derivative · entry 7 Bachrodt Amy · CIK 0002050422 · SVP, Finance 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 41,333 Underlying: Common Stock · 156 shares Expires 2034-12-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025. F5 · derivative.exercise_date: The option vested or vests as to 1/48th of the total award monthly, with the first tranche vested on January 1, 2025, and each subsequent tranche vesting on the monthly anniversary thereof, subject to the reporting person's continued service to the Issuer on each vesting date. Read SEC document |
| February 02, 2026 Filed Feb 4, 2026 16:23 UTC |
Bachrodt AmySVP, Finance
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 4,844 | $0.00 Strike: $10.42 | $0.00 |
DisclosureSEC source: 0002050422-26-000008 · form4-02042026_090208.xml · derivative · entry 6 Bachrodt Amy · CIK 0002050422 · SVP, Finance 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 3,025 Underlying: Common Stock · 4,844 shares Expires 2032-02-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025. F4 · derivative.exercise_date: The option is fully vested. Pursuant to the terms of the reporting person's award agreement with the Issuer, the award became fully vested on February 1, 2026. Read SEC document |
| February 02, 2026 Filed Feb 4, 2026 16:23 UTC |
Bachrodt AmySVP, Finance
|
SaleCommon Stock | 736 | $46.63 | $34,321.37 |
DisclosureSEC source: 0002050422-26-000008 · form4-02042026_090208.xml · nonDerivative · entry 5 Bachrodt Amy · CIK 0002050422 · SVP, Finance 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 12,965 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025. F3 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.365 to $47.23 per share, inclusive. Read SEC document |
| February 02, 2026 Filed Feb 4, 2026 16:23 UTC |
Bachrodt AmySVP, Finance
|
SaleCommon Stock | 4,064 | $46.03 | $187,067.95 |
DisclosureSEC source: 0002050422-26-000008 · form4-02042026_090208.xml · nonDerivative · entry 4 Bachrodt Amy · CIK 0002050422 · SVP, Finance 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 13,701 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025. F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.345 to $46.34 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and in footnote 3 of this Form 4. Read SEC document |
| February 02, 2026 Filed Feb 4, 2026 16:23 UTC |
Bachrodt AmySVP, Finance
|
SaleCommon Stock | 200 | $44.15 | $8,830.00 |
DisclosureSEC source: 0002050422-26-000008 · form4-02042026_090208.xml · nonDerivative · entry 3 Bachrodt Amy · CIK 0002050422 · SVP, Finance 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 17,765 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025. Read SEC document |
| February 02, 2026 Filed Feb 4, 2026 16:23 UTC |
Bachrodt AmySVP, Finance
|
Exercise / conversionCommon Stock | 156 | $10.42 | $1,625.52 |
DisclosureSEC source: 0002050422-26-000008 · form4-02042026_090208.xml · nonDerivative · entry 2 Bachrodt Amy · CIK 0002050422 · SVP, Finance 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 17,965 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025. Read SEC document |
| February 02, 2026 Filed Feb 4, 2026 16:23 UTC |
Bachrodt AmySVP, Finance
|
Exercise / conversionCommon Stock | 4,844 | $10.42 | $50,474.48 |
DisclosureSEC source: 0002050422-26-000008 · form4-02042026_090208.xml · nonDerivative · entry 1 Bachrodt Amy · CIK 0002050422 · SVP, Finance 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 17,809 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025. Read SEC document |
| February 02, 2026 Filed Feb 4, 2026 21:25 UTC |
Bernstein HaroldPresident, R&D & CMO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $10.42 | $0.00 |
DisclosureSEC source: 0002050172-26-000009 · form4-02042026_090238.xml · derivative · entry 6 Bernstein Harold · CIK 0002050172 · President, R&D & CMO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 297,407 Underlying: Common Stock · 15,000 shares Expires 2032-10-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025. F5 · derivative.exercise_date: The option vested as to 1/4th of the total award on October 3, 2023, and thereafter vested or vests as to 1/48th of the total award on the monthly anniversary thereof, subject to the reporting person's continued service to the Issuer on each vesting date. Read SEC document |
| February 02, 2026 Filed Feb 4, 2026 21:25 UTC |
Bernstein HaroldPresident, R&D & CMO
|
SaleCommon Stock | 100 | $47.23 | $4,723.00 |
DisclosureSEC source: 0002050172-26-000009 · form4-02042026_090238.xml · nonDerivative · entry 5 Bernstein Harold · CIK 0002050172 · President, R&D & CMO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.